Page results
-
Researchers at the NIHR UCLH Clinical Research Facility are the first in the world to start a new first-in-human trial investigating a novel treatment, called NVG-111, in patients with Non-Hodgkin lymphoma (NHL) subtypes.
-
We want to make you aware that our children and young people’s teams will be available throughout the holiday period to provide advice and support when needed.
-
The Hyperacute Stroke Unit (HASU) and the Transient Ischaemic Attack (TIA) services were relocated from the seventh floor of University College Hospital to The National Hospital for Neurology and Neurosurgery (NHNN) on 20 March 2020 as part of UCLH’s response to the Covid-19 pandemic.
-
A study at UCLH has found a combination treatment of immunotherapy with an experimental drug may reverse a cancer’s resistance to immunotherapy – making the cancer sensitive to treatment again.
-
"Patient-initiated follow-up” appointments (PIFU ) allow you to arrange a follow-up appointment if and when you need it.
-
The Government has now set out further action aimed at tackling rising cases of the COVID-19 B1.617.2 variant of COVID-19 (also known as the Indian variant).
-
Research conducted at UCLH has discovered how some skin cancers stop responding to treatment at the end of life.
-
UCLH Charity’s magazine, Charity Matters is out now.
-
I worked as a senior directorate accountant in finance in the NHS across a wide range of directorates, both corporate and clinical areas, working closely with these directorates on their financial plans, monitoring and forward planning.
-
The High Court has today ruled in favour of a judicial review claim which means children and young people may not be able to consent to hormone-blocking treatment in cases of gender dysphoria.
File results
-
FOI/2022/0763 - Treatment of dermatological conditions
-
FOI/2022/0764 - Patients treated for drinks spiked/ spiked by needle injection
-
FOI/2022/0768 - Patients treated for Haemophila A
-
FOI/2022/0770 - Parking operations, impact, and parking charge notices issued
-
FOI/2022/0772 - Treatments for rare diseases
-
FOI/2022/0774 - Pre-pregnancy counselling clinics with consultant-led maternity units for women with medical problems
-
FOI/2022/0775 - Data on COVID-19 infections and related illness in staff
-
FOI/2022/0781 - Protocols for diagnosis and treatment of non-small cell lung cancer
-
FOI/2022/0782 - Digital dictation, voice recognition software and outsourced transcription services
-
FOI/2022/0783 - Separate units/ beds allocated for delivery of CAR-T therapy and BMT services